In this episode of "Zoo to You," we discuss a new study where researchers used psilocybin to treat people with post-treatment ...
There have been two measles-associated deaths in Wisconsin. The state has seen 649 cases, including 14 hospitalizations, ...
The novel antiretroviral combination regimen bictegravir-lenacapavir maintains high viral suppression rates, even in the ...
The Measles Collaborative executive director Patsy Stinchfield, PNP, MS, sat down with us to speak about the collaboration ...
Gram-negative pathogens from patients with ventilator-associated pneumonia (VAP) are more resistant than those from ... Two ...
Twice-yearly lenacapavir may foster improved treatment adherence compared with other pre-exposure prophylaxis (PrEP) regimens ...
Within all of the new research presented at IDWeek 2026, in Washington, D.C., there were several new studies on the ...
Mpox continued to circulate at low levels in the United States during 2024 and 2025, with surveillance findings suggesting a ...
Did you miss IDWeek this year? We’ve got you covered. IDSA program vice chair Paul S. Pottinger, MD, DTM&H, FACP, FIDSA, sat ...
An ongoing Ebola outbreak caused by the Bundibugyo virus in the Democratic Republic of Congo (DRC) has become the ...
HPV vaccination coverage among U.S. adolescents remained largely unchanged for a fourth consecutive year in 2025.